Standard regimen works as well as newer drug for arthritis

06/12/2013 | HealthDay News

An older, less expensive regimen that combines methotrexate, sulfasalazine and hydroxychloroquine is as effective as the costlier combination of methotrexate and etanercept in treating rheumatoid arthritis patients who don't respond to methotrexate alone, a study found. U.S. researchers followed 353 patients and found no difference in improvements between the two groups. The study appeared online in the New England Journal of Medicine.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD